Our investments in human health build on Boston’s foundation of biotechnology knowledge and leadership. Converging biology, materials, engineering, and AI to empower a healthy, vibrant world.
“The Engine lives and breathes the principles around the convergence of different disciplines, and that makes it special. Not only do they have industry-leading expertise in biotech and pharma, they also bring impressive background in software and hardware. Cellino exists at the interface of all of these specialties, and we’ve benefited greatly from having an investor like The Engine who speaks all of these languages.”